Le Lézard
Classified in: Business
Subject: v

Canadian General Investments, Limited Declares Dividend on Series 4 Preference Shares


TORONTO, Canada, July 18, 2018 (GLOBE NEWSWIRE) -- Canadian General Investments, Limited (TSX:CGI) (TSX:CGI.PR.D) (LSE:CGI) has declared a quarterly dividend on its Series 4 preference shares.

A cash dividend of $0.23438 per share is payable on September 15, 2018 to shareholders of the Company's 3.75% Cumulative Redeemable Class A Preference Shares, Series 4 of record at the close of business on August 31, 2018.

This dividend is designated as an "eligible dividend" for purposes of the Income Tax Act (Canada).

FOR FURTHER INFORMATION PLEASE CONTACT:
Jonathan A. Morgan
President & CEO
Phone: (416) 366-2931
Fax: (416) 366-2729
e-mail: [email protected]
website: www.canadiangeneralinvestments.ca


These press releases may also interest you

at 14:47
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Innoviz Technologies Ltd. between April 21, 2021 and February 28, 2023, both dates inclusive (the "Class Period"), of the important May 14, 2024 lead...

at 14:30
Transaction in Own Shares 28 March, 2024 ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? Shell plc (the ?Company') announces that on 28 March 2024 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according...

at 14:30
Southwest Airlines Co.  announces the acquisition of SAFFiRE Renewables, LLC (SAFFiRE) as part of the investment portfolio of its wholly owned subsidiary Southwest Airlines Renewable Ventures, LLC (SARV). SARV is dedicated to creating more...

at 14:28
Nuventive, the data-informed improvement companytm, today announced a partnership with D2L, a global learning technology company, to simplify student outcomes analysis and advancement. By linking reports from the D2L Brightspace learning management...

at 14:25
Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and...

at 14:20
Koryx Copper Inc. ("Koryx" or the "Company") announces that the Company has closed a non-brokered private placement (the "Offering") for a total gross proceed of $1,505,250. The Offering closed 23,157,692 units of the Company (each, a "Unit") at...



News published on and distributed by: